<div id="readability-page-1">The flow of information is constant and sometimes overwhelming on Wall Street. Trying to interpret an onslaught of earnings reports and monthly economic data releases each quarter can easily allow something of importance to go unnoticed. For example, May 15 marked the deadline for institutional investors with at least $100 million in assets under management to file Form 13F with the Securities and Exchange Commission. This is a required filing no later than 45 calendar days following the end to a quarter that provides investors with an up-close look at which stocks, exchange-traded funds (ETFs), and select options Wall Street's smartest asset managers have been buying and selling. As you might have guessed, Berkshire Hathaway's billionaire CEO Warren Buffett tends to be the most-followed of all money managers -- but he's not the only billionaire fund manager known for their investing prowess. <div><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84MjYwMDcvc2lsdmVyLWRpY2UtYnV5LXNlbGwtc3RvY2stY2hhcnQtdm9sdW1lLWJpbGxpb25haXJlLWdldHR5LmpwZyZ3PTcwMA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="700" height="525" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84MjYwMDcvc2lsdmVyLWRpY2UtYnV5LXNlbGwtc3RvY2stY2hhcnQtdm9sdW1lLWJpbGxpb25haXJlLWdldHR5LmpwZyZ3PTcwMA"/>Image source: Getty Images. </div> The aptly dubbed &#34;Warren Buffett of Britain,&#34; billionaire Terry Smith of Fundsmith, is another asset manager investors closely follow. Smith is an ardent value investor who, like Buffett, has an exceptional track record of spotting phenomenal deals hiding in plain sight. Over a four-quarter period (April 1, 2024 – March 31, 2025), Fundsmith's 13Fs show Terry Smith completely dumped Berkshire Hathaway's No. 1 holding, Apple (AAPL -0.08%), and more than 11X'd his fund's stake in a company whose addressable market is expected to grow by a compound annual rate of 10.5% through 2032. <h2>Britain's top billionaire value investor sent Apple stock packing</h2> For more than half a decade, Apple has been Berkshire Hathaway's top holding. Buffett has come to appreciate the exceptional loyalty Apple's customers show to the brand, CEO Tim Cook's leadership in building up its higher-margin subscription services segment, and Apple's world-leading capital-return program. Since kicking off its share-repurchase program in 2013, Apple has bought back around $775 billion worth of its own stock and reduced its outstanding share count by more than 43%. This has had a positive impact on earnings per share (EPS) and has made Apple stock more fundamentally attractive to value-seeking investors. Despite these positives, the Warren Buffett of the U.K. exited his fund's entire stake in Apple over the last year, with 1,597,544 shares being sold. One possible reason behind this selling activity is simple profit-taking. Between the third quarter of 2022, which is when Fundsmith first opened a position in Apple, and sometime in the third quarter of 2024, which is when Terry Smith sent these shares to the chopping block, shares of the company rallied from roughly the $150s to the $220s. This is a really nice gain for a megacap company in just two years, and may have enticed Fundsmith's billionaire chief to take his chips off the table. But there may be more to this selling activity than meets the eye. For instance, Apple isn't the value stock it once was. Between 2015 and 2019, investors could buy shares of the iPhone-maker for anywhere between 10 and 20 times trailing-12-month (TTM) EPS. But as of this writing following the close of trading on July 21, Apple is trading at a lofty 33 times TTM EPS. Not only is the stock market at one of its priciest valuations spanning more than 150 years, but it's been a long time since Apple stock was consistently this pricey. What makes Apple's multiple expansion all the more egregious, and may signal why Terry Smith kicked the stock to the curb, is the company's complete lack of growth. Between the end of fiscal 2021 and fiscal 2024 (Apple's fiscal year ends in late September), its net income actually fell from $94.7 billion to $93.7 billion. But because of Apple's aggressive share buyback program, its EPS rose from $5.67 to $6.11. If investors dig beneath the headline numbers, they'll discover that Apple's physical devices have been a drag for more than three years. Though it's possible Apple's investments in artificial intelligence (AI) will reignite its growth engine, a historically pricey stock sporting no growth in net income is an unfavorable combination. <div><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84MjYwMDcvZ3JhbmRmYXRoZXItaG9sZGluZy1wb29kbGUtZG9nLWZhbWlseS1wZXQtY29tcGFuaW9uLWFuaW1hbC1jYXJlLWdldHR5LmpwZyZ3PTcwMA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="700" height="466" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84MjYwMDcvZ3JhbmRmYXRoZXItaG9sZGluZy1wb29kbGUtZG9nLWZhbWlseS1wZXQtY29tcGFuaW9uLWFuaW1hbC1jYXJlLWdldHR5LmpwZyZ3PTcwMA"/>Image source: Getty Images. </div> <h2>Billionaire Terry Smith believes this stock has legs</h2> Like Berkshire's Warren Buffett, Fundsmith's billionaire investor has been highly selective about his buying activity. Since the end of March 2024, Terry Smith has added to seven existing holdings and purchased stakes in four new stocks. Among these 11 buys, the one that really stands out is animal health medicines and diagnostics company Zoetis (ZTS -0.25%). For more than three years, Smith's fund had been holding in the neighborhood of 220,000 to 265,000 shares of Zoetis each quarter. But during the first quarter, 2,319,158 shares of Zoetis stock were purchased, which increased Fundsmith's position by 1,020% in just three months. One logical reason to believe Zoetis has legs is the virtually unstoppable growth in the global animal health market. Between medicines needed for livestock and the ever-expanding companion animal market (e.g., dogs and cats), Polaris Market Research projects the global animal health market will grow from $67 billion in 2024 to $149 billion by 2032. Additionally, sales data from the American Pet Products Association shows that U.S. pet industry expenditures don't decline on a year-over-year basis, regardless of the challenges thrown pet owners' way. Pets are often viewed as members of the family, and owners have demonstrated a willingness to spend freely to ensure the health and happiness of their &#34;family&#34; member. Beyond macro catalysts, billionaire Terry Smith is likely impressed by Zoetis being in the pole position among animal health companies. Zoetis has the largest share of the global animal health market, with north of 300 products spanning eight animal species, and 17 therapies generating at least $100 million in annual sales. Even though brand-name therapies have a finite period of sales exclusivity, the growth, pricing power, and superior margins associated with introducing novel drugs is well worth it. Furthermore, Zoetis has demonstrated a willingness to grow inorganically in order to expand its ecosystem of products and services. Since this decade began, it acquired Performance Livestock Analytics and Fish Vet Group to improve its diagnostic capabilities, and purchased Basepaws, which is a pet-care genetics company that ties into its diagnostic and novel-drug development programs. The steady expansion of Zoetis' ecosystem ensures that the loss of sales exclusivity on a single drug won't rock the boat. Lastly, billionaire Terry Smith may be attracted to Zoetis' reasonable valuation. Based on Wall Street's consensus EPS for 2026, Zoetis stock is trading at less than 22 times forecast EPS. This represents a 34% discount to its average forward-year earnings multiple over the trailing half-decade. </div>

AAPL

AAPB

AAPD

AAPU

AAPX

AAPY

APLY

Billionaire Terry Smith of Fundsmith has sold his entire stake in Apple, a significant move given Apple's long-standing position as a top holding for Berkshire Hathaway. Smith's decision comes after Apple shares rose from the $150s to the $220s, prompting profit-taking. He has instead increased his investment in Zoetis, a company in the animal health sector, which has a promising addressable market projected to reach $149 billion by 2032. This shift reflects Smith's strategy of focusing on value and growth potential in his investments.

- The article discusses the recent filing of Form 13F by institutional investors, highlighting significant moves by billionaire fund managers like Warren Buffett and Terry Smith.  
- Terry Smith sold his entire stake in Apple, citing profit-taking and concerns over the stock's high valuation despite stagnant net income, while significantly increasing his investment in Zoetis due to its growth potential in the animal health market.  
- The global animal health market is projected to grow substantially, and Zoetis holds a leading position with a diverse product range, making it an attractive investment for Smith.

Motley Fool

Apple

Zoetis

GraniteShares 2x Long AAPL Daily ETF

Direxion Daily AAPL Bear 1x Shares

Direxion Daily AAPL Bull 2X Shares

T-Rex 2X Long Apple Daily Target ETF

Kurv Yield Premium Strategy Apple Aapl ETF

YieldMax AAPL Option Income Strategy ETF

Billionaire Terry Smith Sold Fundsmith's Entire Stake in Apple and 11X'd His Position in a Company Whose Addressable Market Can Hit $149 Billion by 2032